Does ROLAPITANT Cause Malignant neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with ROLAPITANT (Varubi). This represents 0.9% of all adverse event reports for ROLAPITANT.
8
Reports of Malignant neoplasm progression with ROLAPITANT
0.9%
of all ROLAPITANT reports
1
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ROLAPITANT?
Of the 8 reports, 1 (12.5%) resulted in death, 2 (25.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROLAPITANT. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ROLAPITANT Cause?
Death (241)
Flushing (92)
Nausea (80)
Dyspnoea (74)
Infusion related reaction (65)
Erythema (54)
Feeling hot (47)
Dizziness (45)
Hospitalisation (36)
Back pain (32)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ROLAPITANT Alternatives Have Lower Malignant neoplasm progression Risk?
ROLAPITANT vs ROMIDEPSIN
ROLAPITANT vs ROMIPLOSTIM
ROLAPITANT vs ROMOSOZUMAB
ROLAPITANT vs ROMOSOZUMAB-AQQG
ROLAPITANT vs ROPEGINTERFERON ALFA-2B-NJFT